| OSMCX | TCMIX | OSMCX / TCMIX | |
| Total Expense Ratio | 2.13 | 1.05 | 203% |
| Annual Report Gross Expense Ratio | 2.13 | 1.11 | 192% |
| Fund Existence | 28 years | 13 years | - |
| Gain YTD | 15.981 | 29.220 | 55% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.76B | 120M | 2,298% |
| Annual Yield % from dividends | 0.48 | 2.39 | 20% |
| Returns for 1 year | 0.82 | 24.44 | 3% |
| Returns for 3 years | 2.40 | 43.81 | 5% |
| Returns for 5 years | -27.38 | 16.69 | -164% |
| Returns for 10 years | 7.46 | 62.01 | 12% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SVXFX | 74.21 | 0.58 | +0.79% |
| Smead International Value I1 | |||
| WSTYX | 83.25 | 0.14 | +0.17% |
| Macquarie Science and Technology Y | |||
| AWSSX | 18.36 | N/A | N/A |
| Invesco Global Core Equity R6 | |||
| CSMIX | 45.80 | -0.01 | -0.02% |
| Columbia Small Cap Value Discv A | |||
| CLTCX | 16.37 | -0.07 | -0.43% |
| Catalyst/Lyons Tactical Allocation C | |||